SMITHSONIAN INSTITUTION 



Statement of Financial Activity For the Year Ended September 30, 1997 (In thousands) 





Unrestricted 





Temporarily 



Permanently 













Trust 



Federal 





Restricted 



Restricted 





Funds 



Funds 



Total 



Trust Funds 



Trust Funds 



Total 



$ — 



383,468 



383,468 







383,468 



56,703 



— 



56,703 



— 



— 



56,703 



1,885 



— 



1,885 



39 



— 



1,924 



12,299 



— 



12,299 



5,452 



423 



18,174 



7,708 



— 



7,708 



— 



— 



7,708 



14,055 



— 



14,055 



— 



— 



14,055 



202,467 



— 



202,467 



— 



— 



202,467 



Operating revenue and gains: 



Government funding and other revenue: 

 Federal appropriations (note 2) 

 Government grants and contracts 

 Short-term investment income (note 9) 

 Endowment payout (note 9) 

 Private grants 



Rentals, fees, and commissions 

 Auxiliary activities 



Total government funding and other revenue 



295,117 



383,468 



678,585 



5,491 



423 



684,499 



Contributions: 

 Program support 

 Construction of facilities 



24,031 



— 



24,031 



7,378 

 6,422 



6,515 



37,924 

 6,422 



Total contributions 



24,031 



— 



24,031 



13,800 



6,515 



44,346 



Total operating revenue and gains 

 Net assets released from restrictions 



319,148 

 16,370 



383,468 



702,616 

 16,370 



19,291 

 (16,370) 



6,938 



728,845 



Total operating revenue, gains and other additions 



Expenses: 



Research 



Collections management 



Education, public programs, and exhibitions 



Auxiliary activities 



Administration 



Advancement 



335,518 



383,468 



718,986 



2,921 



68,201 

 1,535 

 55,792 

 183,369 

 29,076 

 16,078 



119,638 

 53,595 

 70,827 



93,827 



187,839 

 55,130 

 126,619 

 183,369 

 122,903 

 16,078 



- 



354,051 



337,887 



691,938 



— 



(18,533) 

 75,988 



45,581 



27,048 

 75,988 



2,921 

 33,299 



6,938 



728,845 



187,839 

 55,130 

 126,619 

 183,369 

 122,903 

 16,078 



Total expenses 



691,938 



Increase (decrease) in net assets from operations 



Endowment return reinvested (note 9) 



Change in net assets related to collection items not capitalized (note 6): 



6,938 

 (4) 



36,907 

 109,283 



Proceeds from sale 

 Collection items purchased 



2,719 

 (7,359) 



(1.999) 



2,719 

 (9,358) 



— 



— 



2,719 

 (9,358) 



Net increase in net assets 



52,815 



43,582 



96,397 



36,220 



6,934 



139,551 



Net assets, beginning of the year 

 Net assets, end of the year 



426,375 

 S 479,190 



352,610 

 396,192 



778,985 

 875,382 



142,746 

 178,966 



49,528 

 56,462 



971,259 

 1,110,810 



See accompanying notes to the financial statements. 



SMITHSONIAN INSTITUTION 



Statement of Cash Flows For the Year ended September 30, 1997 (In thousands) 



Trust 



Federal 



Total 



Funds 



Funds 



Funds 



$ 95,969 



43,582 



139,551 



(2,719) 



_ 



(2,719) 



7,359 



1,999 



9,358 



6,773 



31,165 



37,938 



1,109 



230 



1,339 



(2,916) 



— 



(2,916) 



(6,422) 



— 



(6,422) 



— 



(52,850) 



(52,850) 



(419) 



— 



(419) 



792 



— 



792 



(107,160) 



— 



(107,160) 



(8,593) 



(971) 



(9,564) 



6,603 



— 



6,603 



(300) 



— 



(300) 



1,105 



163 



1,268 



(99) 



5,685 



5,586 



2,555 



— 



2,555 



Cash flows from operating activities: 

 Net increase in net assets 



Adjustments to reconcile net increase (decrease) in net assets to net 

 cash provided by operating activities: 

 Proceeds from sales of collections 

 Collection items purchased 

 Depreciation 



Loss on disposition of assets 

 Contributions for increases in endowment 

 Contributions for construction of property 



Appropriations for repair and restoration and construction of property 

 Investment income restricted for long-term investment 

 Provision for doubtful accounts 

 Net realized and unrealized gain on sale of securities 

 Decrease (increase) in assets: 



Receivables and advances 



Prepaid and deferred expenses 



Other assets 



Inventory 

 Increase (decrease) in liabilities: 



Accounts payable and accrued expenses 



Deferred revenue 



308 



